IP Library Assignment 026480/0454
Patent Assignment
Reel/Frame 026480/0454

Change of Name

Recorded: 2011-06-20 Received: 2011-06-20 Pages: 5
Assignor
BIOVITRUM AB
Executed: 2006-08-17
Assignee
BIOVITRUM AB (PUBL)
112 76 STOCKHOLM, STOCKHOLM, SEX, SWEDEN
Covered Properties (25)
Benzofuran Compounds
Application: 12/892,765 →
Malate Salt of (2R)-Methyl-1- {3-[2-(3-Pyridinyloxy)Ethoxy]-2-Pyrazinyl}Piperazine
Application: 12/817,833 →
Benzofuran Compounds
Application: 12/781,355 →
Aryl Sulfonamide Compounds for Treating Obesity
Application: 11/960,045 →
4-Substituted Indole and Indoline Compounds
Application: 11/824,939 →
Substituted Naphthalene Sulfonamides
Application: 11/510,324 →
Substituted Sulphonamide Compound and Uses Thereof
Application: 11/447,524 →
Phosphoric Acid Addition Salt of (2R)-1-[3-(2-{[2-(2-Dimethylaminoethoxy)-3-Pyridinyl]Oxy}-Ethoxy)-2-Pyrazinyl]-2-Methylpiperazine
Application: 11/359,152 →
Substituted Sulfonamide Compounds Useful for the Prophylaxis and Treatment of Conditions Relating to Obesity, Type Ii Diabetes and/or Disorders of the Central Nervous System
Application: 11/215,173 →
New Compounds
Application: 11/214,523 →
Novel Compounds, Their Use and Preparation
Application: 11/057,033 →
New Benzofuran Compounds
Application: 11/018,019 →
Certain Arylaliphatic and Heteroaryl-Aliphatic Piperazinyl Pyrazines and Their Use in the Treatment of Serotonin-Related Diseases
Application: 10/873,852 →
Pyrimidine Compounds and Their Use
Application: 10/618,868 →
Novel Compounds, Their Use and Preparation
Application: 10/464,422 →
Process for the Preparation of Stable Acid Addition Salt of 2,3-Disubstituted Pyrazine Compounds
Application: 10/464,181 →
Novel Compounds and Their Use
Application: 10/440,011 →
Certain Arylaliphatic and Heteroaryl-Aliphatic Piperazinyl Pyrazines and Their Use in the Treatment of Serotonin-Related Diseases
Application: 10/269,670 →
Bicyclic Sulfonamide Compounds
Application: 10/167,141 →
New Compounds
Application: 10/144,677 →
Arylsulfonamide Compounds
Application: 10/143,335 →
Novel Compounds and Their Use
Application: 09/989,358 →
Novel Compounds and Their Use
Application: 09/988,966 →
Novel Compounds, Their Use and Preparation
Application: 10/037,110 →
Pharmaceutical Combination Formulation and Method of Treatment with the Combination
Application: 09/908,801 →